Clinical Trial: REMS vs DXA for Osteoporosis Diagnosis and Fracture Risk Prediction

U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07876882) titled 'REMS vs DXA for Osteoporosis Diagnosis and Fracture Risk Prediction' on Oct. 09.

Brief Summary: This prospective, observational, comparative diagnostic study will evaluate the performance of Radiofrequency Echographic Multi Spectrometry (REMS) for the diagnosis of osteoporosis and prediction of fragility fracture risk in a U.S. population, using dual-energy X-ray absorptiometry (DXA) as the reference standard. Approximately 250 male and female participants aged 30-90 years who are undergoing evaluation for bone health will be enrolled at Rheumatology Associates of Delmarva. Participants will have clinically obtained DXA results and ...